Résultats de la recherche - 18 results
Immunovirological and environmental screening reveals actionable risk factors for fatal COVID-19 during post-vaccination nursing home outbreaksAbstract
Publication Type: Peer reviewed scientific article Authors: Cuypers, Lize; Keyaerts, Els; Hong, Samuel Leandro; Gorissen, Sarah; Menezes, Soraya Maria; Starick, Marick; Van Elslande, Jan; Weemaes, ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factorsBackgroundMethodsResultsConclusionDataSheet_1.docx
Vanhoutte, Greetje; Peeters, Bart; Raats, Silke; Massen, Isolde Van der; De Keersmaecker, Sven; Debie, Yana; Huizing, Manon; Pannus, Pieter; Neven, Kristof Y.; Ariën, Kevin K.; Martens, Geert A.; Bulcke, Marc ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
Publication Type: Peer reviewed scientific article Authors: Kemlin, Delphine; Gemander, Nicolas; Stéphanie Depickère; Olislagers, Véronique; Georges, Daphnée; Waegemans, Alexandra; Pannus, Pieter ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Publication Type: Peer reviewed scientific article Authors: Pannus, Pieter; Depickère, Stéphanie; Kemlin, Delphine; Georges, Daphnée; Houben, Sarah; Olislagers, Véronique; Waegemans, Alexandra; De ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults
Publication Type: Peer reviewed scientific article Authors: Pannus, Pieter; Stéphanie Depickère; Kemlin, Delphine; Georges, Daphnée; Houben, Sarah; Olislagers, Véronique; Waegemans, Alexandra; De ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
Publication Type: Peer reviewed scientific article Authors: Pieter Pannus; Stéphanie Depickère; Delphine Kemlin; Sarah Houben; Kristof Y. Neven; Heyndrickx, Leo; Johan Michiels; Willems, Elisabeth; ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
Lisa Verheggen; Debbie Le Blon; Bart Peeters; Maria Goossens; Pieter Pannus; Ariën, Kevin K; Sébastien Anguille; Annelies Janssens; Hans Prenen; Evelien L J Smits; Christof Vulsteke; Eva Lion; Peeters, ...
Predictive model for BNT162b2 vaccine response in cancer patients based on blood cytokines and growth factors.
Vanhoutte; Bart Peeters; Silke Raats; Isolde Van der Massen; Sven De Keersmaecker; Yana Debie; Manon Huizing; Pieter Pannus; Kristof Y Neven; Ariën, Kevin K; Geert A Martens; Marc Van den Bulcke; Ella Roelant; ...
Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients.
Publication Type: Peer reviewed scientific article Authors: Lorenzo Canti; Ariën, Kevin K; I Desombere; Stéphanie Humblet-Baron; Pieter Pannus; Heyndrickx, Leo; Aurélie Henry; Sophie Servais; ...
Humoral and Cellular Immune Responses against SARS-CoV-2 after Third Dose BNT162b2 following Double-Dose Vaccination with BNT162b2 versus ChAdOx1 in Patients with CancerPurpose:Experimental Design:Results:Conclusions:
Marcq, Elly; Verheggen, Lisa; Le Blon, Debbie; Peeters, Bart; Maria Goossens; Pannus, Pieter; Ariën, Kevin K.; Anguille, Sébastien; Janssens, Annelies; Prenen, Hans; Smits, Evelien L.J.; Vulsteke, ...